CRO Indicia Production acquires Biotechnologie Appliquee: Rainbow JV with TheraKine

Indicia Production, a French contract manufacturing organization (CRO) specializing in the aseptic filling and manufacture of ready-to-use microbiological media, has just announced the acquisition of Biotechnologie Appliquee, based in Taden, in Cotes-d’Armor, France. Financial terms of this buyout, completed at the end of February, have not been disclosed.

Biotechnologie Appliquee, with a turnover of 500,000 euros ($653,300) in 2012 and four employees, provides contract manufacturing of ready-to-use media for microbiological testing to the food-processing, pharmaceutical and cosmetic industries. The company is smaller and more flexible than Indicia Production with extensive expertise in subcontracting. It primarily provides low-volume manufacturing. This acquisition therefore complements the range of mass-manufactured products from Indicia Production in Lyon.

Indicia Production can now provide contract services for both high and low volume manufacturing and can also respond to client requirements more quickly. Indicia plans to secure new clients by expanding and diversifying its product range. The company also aims to draw on Biotechnologie Appliquee’s expertise to develop new products throughout 2013.